Andrew Adams is the co-founder and managing partner of Oak HC/FT, a venture capital and growth equity firm investing in the healthcare and fintech sectors with $5.3B AUM. Andrew has spent over 25 years investing in leading healthcare companies. He serves on the Boards of August Bioservices, Curana Health, DispatchHealth, Eating Recovery Center, Galileo, Infusion for Health, Marathon Health, Reveleer, Rialtic, Trovo Health, Unified Women's Healthcare, US HealthVest and Veda. He is also actively involved with Noom and Precision Medicine Group. His prior investments include One Medical (NASDAQ: ONEM acquir...read more